Norges Bank’s Audentes Therapeutics, Inc BOLD Stock Holding History

Norges Bank’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,536	Closed	-$870K	–	2115
2019 Q4	$870K	Sell	14,536 -19,560	-57%	-$734K	﹤0.01%	2030
2019 Q3	$957K	Buy	+34,096	New	+$1.16M	﹤0.01%	2039

Norges Bank's BOLD Position: Q1 2020 in Review

Norges Bank sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 14,536 shares — an estimated $870K sold.

Norges Bank first reported a position in BOLD in Q3 2019 and held it in 2 quarters. The position peaked at $957K in Q3 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Norges Bank reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Norges Bank sold 14,536 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $870K.
Norges Bank first reported a position in Audentes Therapeutics, Inc in Q3 2019 and held it in 2 quarters.
Norges Bank's Audentes Therapeutics, Inc position peaked at $957K in Q3 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Norges Bank's 13F filing for Q1 2020, filed 8 May 2020.